NIH White Paper Brief

The Medical Rx Cost Center

Infusions, Injectables, Biosimilars, and Every J- and Q-Code

Why the biggest drug costs in a self-funded plan hide on the medical claim, and what employers can do about it before the next renewal

By Jake Velie, CPT

Founder, Chairman & CEO, National Integrative Health

Cover of the National Integrative Health NIH White Paper Brief, The Medical Rx Cost Center

Access the Medical Rx Cost Center Brief

Complete this short form for immediate access to the full PDF of the NIH white paper brief.

Please do not submit protected health information, member information, claims data, prescription details, or medical information through this form.

Your information will be handled in accordance with the NIH Privacy Policy.

What You'll Learn

Inside this brief

WHERE THE SPEND HIDES

Why Medical Rx costs sit in the medical claim, out of view—and what Medical Rx covers: infusions, injectables, biosimilars, J- and Q-codes.

SITE OF CARE AND THE STOP-LOSS CONNECTION

Same drug, different chair or a different contract—and how overpaid claims follow you to renewal.

FIVE STEPS AND RENEWAL QUESTIONS

A practical review process for executives, plus what to ask your broker and partners.

Developed for the stakeholders responsible for plan spend

For plan sponsors, brokers, TPAs, and stop-loss partners. Educational content; not legal or clinical advice.